About Aurora

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora’s portfolio of trusted, leading brands includes Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, Tasty’s™, and Whistler Cannabis Co.™. The company also holds a controlling interest in Bevo Farms Ltd., North America’s leading supplier of propagated agricultural plants. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.   

Learn more at www.auroramj.com and follow us on X and LinkedIn. 

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".



Contact Information

For Media
Email: [email protected]
Michelle Lefler, VP, Communications & Public Relations

For Investors
ICR, Inc.
[email protected]

Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.

Latest

Feb 03, 2026, 07:00 ET Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership

NASDAQ | TSX: ACB Launch of improved, localized websites underscores Aurora's long-term strategy for growth and engagement across key European medical markets EDMONTON, AB, Feb. 3, 2026 /CNW/ -...

Jan 21, 2026, 16:35 ET Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced...

Jan 20, 2026, 07:00 ET Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties

NASDAQ | TSX: ACB European grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis company EDMONTON, AB, Jan. 20, 2026 /CNW/ -...

Jan 14, 2026, 07:00 ET Aurora Achieves Significant Progress in Disease Resistance Research

NASDAQ | TSX: ACB As a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in...

Dec 18, 2025, 07:00 ET Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients

NASDAQ | TSX: ACB Daily Special™ launch expands Aurora's leading portfolio of medical cannabis products available in the company's fastest growing market EDMONTON, AB, Dec. 18, 2025 /CNW/ - Aurora...

Dec 11, 2025, 07:00 ET Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland

Latest Innovation Brings New Proprietary Cultivar to Polish Patients NASDAQ | TSX: ACB EDMONTON, AB, Dec. 11, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading...

Dec 08, 2025, 07:00 ET Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year...

Dec 02, 2025, 07:00 ET Aurora Announces Distribution Partnership with Leafio Australia

The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB),...

Nov 05, 2025, 07:00 ET Aurora Cannabis Announces Fiscal 2026 Second Quarter Results

Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record $42.7 million, with leadership positions...

Oct 22, 2025, 17:15 ET Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced...

Sep 18, 2025, 07:00 ET Aurora Announces Investment into German Manufacturing Facility

NASDAQ | TSX: ACB Facility investment includes adopting the company's unmatched global manufacturing practices for superior cannabis production and quality EDMONTON, AB, Sept. 18, 2025 /CNW/ - Aurora ...

Sep 09, 2025, 07:00 ET Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies

NASDAQ | TSX: ACB EDMONTON, AB, Sept. 9, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the launch of the...

Sep 08, 2025, 07:00 ET Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference

NASDAQ | TSX: ACB EDMONTON, AB, Sept. 8, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will be attending the H.C. Wainwright...

Aug 12, 2025, 07:00 ET Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia

Canada's Largest Medical Cannabis Company to Launch Two High-Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...

Aug 08, 2025, 17:00 ET Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to...

Aug 07, 2025, 07:00 ET Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference

Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the ...

Aug 06, 2025, 07:00 ET Aurora Cannabis Announces Fiscal 2026 First Quarter Results

NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue1 by 85% to $37.1 million Delivers Adjusted...

Jul 30, 2025, 07:05 ET Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders

Your vote is important no matter how many shares you own. Please vote today. Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and...

Jul 23, 2025, 17:35 ET Aurora Cannabis to Host First Quarter 2026 Investor Conference Call

NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced...

Jul 16, 2025, 07:00 ET Aurora Continues Deep Commitment to Veterans Through Strains for Heroes Initiative

The veteran-informed product line reinforces the company's patient-first approach NASDAQ | TSX: ACB EDMONTON, AB, July 16, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the...

Jul 14, 2025, 07:00 ET Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre

Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB, July 14, 2025 /CNW/ - Aurora...

Jul 09, 2025, 07:30 ET Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders

Your vote is important no matter how many shares you own. Please vote today. Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and...

Jun 26, 2025, 07:00 ET Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB, June 26, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) ...

Jun 24, 2025, 07:00 ET Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products

Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB, June 24, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB),...

Jun 19, 2025, 07:39 ET Aurora Cannabis Advises of Second False Article from Investing.com

NASDAQ | TSX: ACB EDMONTON, AB, June 19, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.